Roy Robertson

3.4k total citations
84 papers, 2.5k citations indexed

About

Roy Robertson is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Roy Robertson has authored 84 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Epidemiology, 25 papers in Public Health, Environmental and Occupational Health and 15 papers in Infectious Diseases. Recurrent topics in Roy Robertson's work include HIV, Drug Use, Sexual Risk (30 papers), Opioid Use Disorder Treatment (23 papers) and Substance Abuse Treatment and Outcomes (16 papers). Roy Robertson is often cited by papers focused on HIV, Drug Use, Sexual Risk (30 papers), Opioid Use Disorder Treatment (23 papers) and Substance Abuse Treatment and Outcomes (16 papers). Roy Robertson collaborates with scholars based in United Kingdom, Bulgaria and Switzerland. Roy Robertson's co-authors include J. J. Roberts, R A Elton, Barbara Broers, Peter Simmonds, Jeanne E. Bell, R P Brettle, Ildefonso Hernández‐Aguado, James S. McKenzie, David B. Mertz and Robert Zangerle and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Ecology.

In The Last Decade

Roy Robertson

84 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roy Robertson United Kingdom 31 928 599 460 365 345 84 2.5k
Matthew Koch United States 29 542 0.6× 1.0k 1.7× 740 1.6× 341 0.9× 158 0.5× 53 3.4k
Yingying Ding China 25 1.0k 1.1× 765 1.3× 216 0.5× 252 0.7× 85 0.2× 156 2.6k
Ian C. Marschner Australia 28 380 0.4× 658 1.1× 535 1.2× 134 0.4× 476 1.4× 160 3.7k
Roberto Muga Spain 24 1.2k 1.3× 595 1.0× 267 0.6× 703 1.9× 70 0.2× 128 2.3k
Cecilia T. Costiniuk Canada 24 445 0.5× 531 0.9× 576 1.3× 130 0.4× 136 0.4× 100 1.8k
Giustino Parruti Italy 26 649 0.7× 793 1.3× 257 0.6× 117 0.3× 175 0.5× 144 2.4k
Victor De Gruttola United States 29 481 0.5× 1.4k 2.3× 1.1k 2.3× 214 0.6× 164 0.5× 98 4.2k
Yechiel A. Hekster Netherlands 29 257 0.3× 753 1.3× 481 1.0× 137 0.4× 162 0.5× 73 2.7k
Jorge A. Tavel United States 21 528 0.6× 440 0.7× 453 1.0× 206 0.6× 179 0.5× 43 2.5k
David B. Hanna United States 29 771 0.8× 1.1k 1.8× 388 0.8× 186 0.5× 140 0.4× 128 3.1k

Countries citing papers authored by Roy Robertson

Since Specialization
Citations

This map shows the geographic impact of Roy Robertson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Robertson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Robertson more than expected).

Fields of papers citing papers by Roy Robertson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Robertson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Robertson. The network helps show where Roy Robertson may publish in the future.

Co-authorship network of co-authors of Roy Robertson

This figure shows the co-authorship network connecting the top 25 collaborators of Roy Robertson. A scholar is included among the top collaborators of Roy Robertson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy Robertson. Roy Robertson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matheson, Catriona, et al.. (2024). Clinical Outcomes of Benzodiazepine Prescribing for People Receiving Opioid Agonist Treatment: A Systematic Review of the Evidence. SHILAP Revista de lepidopterología. 12(5). 152–152. 4 indexed citations
2.
Whittaker, Anne, Lawrie Elliott, Julie Taylor, et al.. (2022). The Parents under Pressure parenting programme for families with fathers receiving treatment for opioid dependence: the PuP4Dads feasibility study. SHILAP Revista de lepidopterología. 10(3). 1–154. 4 indexed citations
3.
Matheson, Catriona & Roy Robertson. (2022). An avoidable crisis. Harm Reduction Journal. 19(1). 98–98. 1 indexed citations
4.
Robertson, Roy, Barbara Broers, & Magdalena Harris. (2020). Injecting drug use, the skin and vasculature. Addiction. 116(7). 1914–1924. 24 indexed citations
5.
Román-Urrestarazu, Andrés, Justin Yang, Roy Robertson, et al.. (2019). Brexit threatens the UK’s ability to tackle illicit drugs and organised crime: What needs to happen now?. Health Policy. 123(6). 521–525. 5 indexed citations
6.
Gao, Lu, Polyxeni Dimitropoulou, Roy Robertson, et al.. (2016). Risk-factors for methadone-specific deaths in Scotland’s methadone-prescription clients between 2009 and 2013*. Drug and Alcohol Dependence. 167. 214–223. 34 indexed citations
7.
Weller, David, D Coleman, Roy Robertson, et al.. (2007). The UK colorectal cancer screening pilot: results of the second round of screening in England. British Journal of Cancer. 97(12). 1601–1605. 168 indexed citations
8.
Asten, Liselotte van, Robert Zangerle, Ildefonso Hernández‐Aguado, et al.. (2005). Do HIV Disease Progression and HAART Response Vary among Injecting Drug Users in Europe?. European Journal of Epidemiology. 20(9). 795–804. 9 indexed citations
9.
Robertson, Roy, et al.. (2004). Hepatitis B vaccination and injecting drug users.. PubMed. 54(503). 444–7. 15 indexed citations
10.
Bell, Jeanne E., et al.. (2002). HIV and Drug Misuse in the Edinburgh Cohort. JAIDS Journal of Acquired Immune Deficiency Syndromes. 31. S35–S42. 51 indexed citations
11.
Cochrane, Alexandra, Alison Hardie, Roy Robertson, et al.. (2002). A Genetic Analysis of Hepatitis C Virus Transmission between Injection Drug Users. The Journal of Infectious Diseases. 186(9). 1212–1221. 56 indexed citations
12.
Prins, M., Roy Robertson, R.P. Brettle, et al.. (1999). Do gender differences in CD4 cell counts matter?. AIDS. 13(17). 2361–2364. 106 indexed citations
13.
Robertson, Roy. (1998). Management of drug users in the community: a practical handbook.. 11 indexed citations
14.
Robertson, Roy, et al.. (1994). Continued drug use and other cofactors for progression to AIDS among injecting drug users. AIDS. 8(3). 339–344. 54 indexed citations
15.
Robertson, Roy, et al.. (1993). Effect of human immunodeficiency virus infection on the growth of young children†. The Journal of Pediatrics. 123(4). 579–582. 102 indexed citations
16.
Robertson, Roy, et al.. (1993). Initial and current drug use: how are they related?. Addiction. 88(9). 1225–1231. 1 indexed citations
17.
Robertson, Roy, et al.. (1990). After the epidemic: follow up study of HIV seroprevalence and changing patterns of drug use.. BMJ. 300(6719). 219–223. 40 indexed citations
18.
Robertson, Roy. (1989). Treatment of Drug Misuse in the General Practice Setting. British Journal of Addiction. 84(4). 377–380. 6 indexed citations
19.
Folse, Roland, et al.. (1979). Family practice in nonmetropolitan Illinois.. PubMed. 8(4). 799–805. 2 indexed citations
20.
Wheeler, William E., C. H. Noller, C.E. Coppock, Roy Robertson, & P.J. Van Soest. (1974). Accounting for variability in digestible energy of dairy rations by multiple regression analysis. Journal of Dairy Science. 57(5). 621–622. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026